Akoustis Technologies, Inc. (AKTS) Stock Forecast

NASDAQ: AKTSAnalyst ratings, price target and estimates.

AKTS analyst forecast

as of October 18, 2026
Analyst consensus
Strong buy
4.90 / 5 from 10 analysts
Price target
$35.39
average of analyst targets
Upside to target
+135.0%
from the latest close
Next earnings
November 12, 2026
EPS estimate $-0.47
52-week range
$15.06 – $32.23

AKTS analyst ratings

10 analysts
Strong buy
990%
Buy
110%
Hold
00%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

AKTS price target

Price $15.06Target $35.39
52-week low $15.0652-week high $32.23

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

AKTS earnings per share estimates

Akoustis Technologies, Inc. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)−$0.45−$0.56−$0.34——7
Current fiscal year (2026)−$1.68−$1.95−$1.27−$78.34+97.9%8
Next fiscal year (2027)−$2.14−$2.92−$1.08−$1.68−27.2%8

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

AKTS revenue estimates

Akoustis Technologies, Inc. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$2.5M$0$3.5M—8
Current fiscal year (2026)$10.6M$6.6M$13.6M+63.5%9
Next fiscal year (2027)$10.3M$0$35.0M−2.7%9

AKTS EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

AKTS revenue: reported and forecast

Reported revenueEstimate (average; low–high)

AKTS EPS estimate revisions

Akoustis Technologies, Inc. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)−$0.46−$0.44−$0.46−$0.46−$0.45−0.7%2 up · 2 down
Current fiscal year (2026)−$1.62−$1.72−$1.69−$1.69−$1.68+3.6%1 up · 3 down
Next fiscal year (2027)−$1.97−$2.12−$2.15−$2.15−$2.14+8.5%1 up · 3 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

AKTS earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; AKTS beat in 6 of 12.

What analysts expect from AKTS

10 analysts cover Akoustis Technologies; their consensus rating is strong buy (4.90 on a 1–5 scale, where 5 is a strong buy). The average price target is $35.39, 135.0% above the latest close of $15.06. Analysts expect earnings of −$1.68 per share for 2026, +97.9% from a year earlier. For 2027 the average estimate is −$2.14 per share on revenue of $10.3 million. Akoustis Technologies beat the EPS estimate in 6 of the last 12 quarters.

Related: AKTS income statement, AKTS key metrics, AKTS chart. See the AKTS stock overview for the latest quote and news.

AKTS forecast FAQ

What is Akoustis Technologies's price target?

The average analyst price target for Akoustis Technologies is $35.39, 135.0% above the latest close of $15.06.

Is Akoustis Technologies a buy, hold or sell?

Of 10 analysts covering Akoustis Technologies, 9 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.

What is Akoustis Technologies's EPS forecast?

Analysts forecast −$1.68 per share for 2026 (range −$1.95 to −$1.27); for 2027 the estimate is −$2.14.

What is Akoustis Technologies's revenue forecast?

The average revenue estimate for 2026 is $10.6 million, growth of 63.5%; for 2027 it is $10.3 million.

When does Akoustis Technologies report earnings?

Akoustis Technologies is expected to report results for the quarter ending September 30, 2026 on November 12, 2026 after the market closes; the EPS estimate is $-0.47.

Does Akoustis Technologies usually beat earnings estimates?

Akoustis Technologies reported EPS at or above the analyst estimate in 6 of the last 12 quarters.

Biotechnology: forecast